Healis announces collaboration with MGH to advance neuroscience research
26 Mar 2024 //
GLOBENEWSWIRE
Healis`s asset CKDB-501A shares Ph III topline results for glabellar injections
27 Feb 2024 //
GLOBENEWSWIRE
Healis selected to present at biotechnology & neuroscience investor conferences
12 Feb 2024 //
GLOBENEWSWIRE
Healis Announces Supply Agreement with CKD Bio to develop CKDB-501
02 Jan 2024 //
GLOBENEWSWIRE
Healis Therapeutics selected to speak on opening day of 2024 Biotech Showcase
05 Dec 2023 //
GLOBENEWSWIRE